Kura Oncology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
32.22
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
6
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.56
|
-0.53
|
0.03
|
5.36%
|
|
2022-06-30
|
-0.52
|
-0.52
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.52
|
-0.49
|
0.03
|
5.77%
|
|
2021-12-31
|
-0.53
|
-0.49
|
0.04
|
7.55%
|
|
2021-09-30
|
-0.54
|
-0.50
|
0.04
|
7.41%
|
|
2021-06-30
|
-0.49
|
-0.51
|
-0.02
|
-4.08%
|
|
2021-03-31
|
-0.42
|
-0.46
|
-0.04
|
-9.52%
|
|
2020-12-31
|
-0.45
|
-0.45
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.54
|
|
2021-12-31
|
-1.96
|
|
2020-12-31
|
-1.69
|
|
2019-12-31
|
-1.50
|
|
2018-12-31
|
-1.73
|
|
2017-12-31
|
-1.54
|
|
2016-12-31
|
-1.47
|
|
2015-12-31
|
-0.99
|